Post-transcriptional checkpoints in autoimmunity

被引:0
作者
Rami Bechara
Stephan Vagner
Xavier Mariette
机构
[1] Université Paris-Saclay,Institut Curie, CNRS UMR3348, INSERM U1278
[2] Inserm,undefined
[3] CEA,undefined
[4] Immunologie des maladies virales,undefined
[5] auto-immunes,undefined
[6] hématologiques et bactériennes (IMVA-HB/IDMIT/UMR1184),undefined
[7] PSL Research University,undefined
[8] Université Paris-Saclay,undefined
[9] Assistance Publique – Hôpitaux de Paris,undefined
[10] Hôpital Bicêtre,undefined
[11] Department of Rheumatology,undefined
来源
Nature Reviews Rheumatology | 2023年 / 19卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Post-transcriptional regulation is a fundamental process in gene expression that has a role in diverse cellular processes, including immune responses. A core concept underlying post-transcriptional regulation is that protein abundance is not solely determined by transcript abundance. Indeed, transcription and translation are not directly coupled, and intervening steps occur between these processes, including the regulation of mRNA stability, localization and alternative splicing, which can impact protein abundance. These steps are controlled by various post-transcription factors such as RNA-binding proteins and non-coding RNAs, including microRNAs, and aberrant post-transcriptional regulation has been implicated in various pathological conditions. Indeed, studies on the pathogenesis of autoimmune and inflammatory diseases have identified various post-transcription factors as important regulators of immune cell-mediated and target effector cell-mediated pathological conditions. This Review summarizes current knowledge regarding the roles of post-transcriptional checkpoints in autoimmunity, as evidenced by studies in both haematopoietic and non-haematopoietic cells, and discusses the relevance of these findings for developing new anti-inflammatory therapies.
引用
收藏
页码:486 / 502
页数:16
相关论文
共 591 条
[1]  
Theofilopoulos AN(2017)The multiple pathways to autoimmunity Nat. Immunol. 18 716-724
[2]  
Kono DH(2011)Genomics and the multifactorial nature of human autoimmune disease N. Engl. J. Med. 365 1612-1623
[3]  
Baccala R(2020)Challenges, progress, and prospects of developing therapies to treat autoimmune diseases Cell 181 63-80
[4]  
Cho JH(2014)Immunology of relapse and remission in multiple sclerosis Annu. Rev. Immunol. 32 257-281
[5]  
Gregersen PK(2021)Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases Nat. Rev. Rheumatol. 17 585-595
[6]  
Fugger L(2020)mRNAs, proteins and the emerging principles of gene expression control Nat. Rev. Genet. 21 630-644
[7]  
Jensen LT(2022)The relationship of mRNA with protein expression in CD8 PLoS One 17 269-283.e19
[8]  
Rossjohn J(2020) T cells associates with gene class and gene characteristics Cell 183 275-287
[9]  
Steinman L(2013)A quantitative proteome map of the human body Nat. Rev. Genet. 14 77-96
[10]  
Szekanecz Z(2021)How cells get the message: dynamic assembly and function of mRNA–protein complexes Immunol. Rev. 304 120-129